Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors

Abroad (travel likely)Recruiting

Conditions

Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Service pharmaceutique, Unité de Pharmacie Clinique Oncologique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
Contact: Study coordinator (Catherine RIOUFOL, PharmD) · catherine.rioufol@chu-lyon.fr · 04 78 86 43 70
Contact: Study coordinator (Laure HUOT, PharmD) · laure.huot@chu-lyon.fr · 04 72 11 57 62

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

Cancer Survivors · Peripheral Neuropathic Pain

Abroad (travel likely)Recruiting

Montpellier, France

Urine Methylation Markers in UTUC

Upper Tract Urothelial Cancer

Abroad (travel likely)Recruiting

Durham, United States

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Breast Cancer · Quality of Life

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Breast Cancer Stage I · Breast Cancer Stage II · Breast Cancer Stage III

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States